ANI Pharmaceuticals (ANIP) News Today $93.50 +0.97 (+1.05%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$93.74 +0.24 (+0.26%) As of 08/29/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Walleye Capital LLC Sells 40,725 Shares of ANI Pharmaceuticals, Inc. $ANIPAugust 31 at 4:35 AM | marketbeat.comJump Financial LLC Makes New $1.56 Million Investment in ANI Pharmaceuticals, Inc. $ANIPAugust 31 at 4:34 AM | marketbeat.comNuveen LLC Acquires Shares of 48,601 ANI Pharmaceuticals, Inc. $ANIPAugust 31 at 3:15 AM | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 12-Month High - Still a Buy?August 28, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) SVP Sells 1,763 Shares of StockAugust 27, 2025 | marketbeat.comVirtus Advisers LLC Takes $922,000 Position in ANI Pharmaceuticals, Inc. $ANIPAugust 27, 2025 | marketbeat.comANI Pharmaceuticals, Inc. $ANIP Stock Holdings Boosted by Hotchkis & Wiley Capital Management LLCAugust 27, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Director Sells $229,087.36 in StockAugust 27, 2025 | insidertrades.comStonepine Capital Management LLC Has $3.21 Million Stock Holdings in ANI Pharmaceuticals, Inc. $ANIPAugust 26, 2025 | marketbeat.comPenn Capital Management Company LLC Invests $448,000 in ANI Pharmaceuticals, Inc. $ANIPAugust 26, 2025 | marketbeat.comKrista Davis Sells 1,763 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) StockAugust 26, 2025 | insidertrades.comVanguard Group Inc. Sells 132,901 Shares of ANI Pharmaceuticals, Inc. $ANIPAugust 26, 2025 | marketbeat.comANI Pharmaceuticals to Present at Upcoming Investor ConferencesAugust 25, 2025 | globenewswire.comANI Pharmaceuticals (NASDAQ:ANIP) Upgraded to "Strong-Buy" at Zacks ResearchAugust 25, 2025 | marketbeat.comQuantbot Technologies LP Takes $1.31 Million Position in ANI Pharmaceuticals, Inc. $ANIPAugust 25, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) COO Sells $4,243,773.24 in StockAugust 25, 2025 | americanbankingnews.comAdvantage Alpha Capital Partners LP Increases Stake in ANI Pharmaceuticals, Inc. $ANIPAugust 24, 2025 | marketbeat.comMuthusamy Shanmugam Sells 52,988 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) StockAugust 24, 2025 | americanbankingnews.comANI Pharmaceuticals (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 47,012 SharesAugust 23, 2025 | insidertrades.com1 Mooning Stock for Long-Term Investors and 2 That UnderwhelmAugust 22, 2025 | finance.yahoo.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 1-Year High - Time to Buy?August 22, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Director Antonio Pera Sells 5,421 SharesAugust 21, 2025 | insidertrades.comANI Pharmaceuticals (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 52,990 SharesAugust 21, 2025 | americanbankingnews.comANI Pharmaceuticals (NASDAQ:ANIP) COO Sells $4,206,454.80 in StockAugust 21, 2025 | americanbankingnews.comPublic Sector Pension Investment Board Has $3.53 Million Stock Holdings in ANI Pharmaceuticals, Inc. $ANIPAugust 21, 2025 | marketbeat.comMatthew J. Leonard Sells 6,937 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) StockAugust 20, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Director Sells 9,000 Shares of StockAugust 20, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) SVP Sells $1,739,400.00 in StockAugust 20, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Sells 47,010 Shares of StockAugust 20, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Sells $4,618,078.50 in StockAugust 20, 2025 | marketbeat.comQ2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals SegmentAugust 20, 2025 | msn.comANI Pharmaceuticals (NASDAQ:ANIP) Releases FY 2025 Earnings GuidanceAugust 19, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Aberdeen Group plcAugust 19, 2025 | marketbeat.comANI Pharmaceuticals, Inc. $ANIP Stock Position Lifted by Russell Investments Group Ltd.August 19, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Director Sells $611,635.29 in StockAugust 19, 2025 | insidertrades.com3 Healthcare Stocks We’re Skeptical OfAugust 18, 2025 | finance.yahoo.comANI Pharmaceuticals (ANIP) Receives a Buy from Leerink PartnersAugust 17, 2025 | theglobeandmail.comANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Upgraded by Wall Street ZenAugust 17, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells 400 Shares of StockAugust 16, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) SVP Thomas Andrew Rowland Sells 4,975 SharesAugust 16, 2025 | marketbeat.comOri Gutwerg Sells 5,873 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) StockAugust 16, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Director Thomas Haughey Sells 19,341 SharesAugust 16, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CFO Sells 50,000 Shares of StockAugust 16, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 56,960 Shares of StockAugust 16, 2025 | marketbeat.comThe 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings CallAugust 16, 2025 | msn.comDeutsche Bank AG Trims Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)August 16, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Meredith Cook Sells 400 SharesAugust 15, 2025 | insidertrades.comMitsubishi UFJ Asset Management UK Ltd. Purchases New Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)August 15, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 52-Week High - Here's WhyAugust 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)August 15, 2025 | marketbeat.com Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANIP Media Mentions By Week ANIP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼1.021.11▲Average Medical News Sentiment ANIP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼187▲ANIP Articles Average Week Get the Latest News and Ratings for ANIP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ADMA Biologics News Annovis Bio News Grifols News Revolution Medicines News Rhythm Pharmaceuticals News Legend Biotech News Avidity Biosciences News Axsome Therapeutics News Abivax News Nuvalent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.